In the complex world of chemistry, one can take a direct path from education to industry, as recent Kennesaw State University ...
Chemist Katelynn Perrault Uptmor discussed her work using comprehensive two-dimensional gas chromatography (GC×GC) to improve ...
YouTube on MSN
What salt should you use for cooking?
Description: Why are there so many different kinds of salt, and does it *really* matter which one you use? 𝗧𝗵𝗲 ...
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has ...
News Medical on MSN
RNA-based cocktail shows promise against glioblastoma
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous ...
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia ...
TOULOUSE, France & FULLERTON, Calif. & LISSES, France, November 20, 2025--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible PEA PME), a next-generation biopharma company pioneering a ...
6hon MSN
I finally upgraded from my old Samsung Galaxy S23 — it was the best decision I've made this year
After taking time to tinker with the One UI 7 update (when it finally arrived) on my Samsung Galaxy S23, I decided to throw ...
Motunrayo Oladele, a doctoral researcher and principal investigator at the University of Kentucky in the United States, is ...
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to ...
NDTV Profit on MSN
Biocon Eyes Acceleration Phase As USFDA Draft Guidelines Open Door To Cheaper Biosimilars: Kiran Mazumdar-Shaw
Shaw said Biocon’s growth trajectory over the next five years will be “very exciting,” with even larger opportunities emerging beyond 2030 as big-ticket biologics go off patent.
VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its manufact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results